With the expertise of Darin Zahuranec, MD, MSc, and Adam Stein, MD, the Levine Team has conducted two pilot studies from April to September 2023 in preparation for a November 2023 grant submission.
Pilot 1 involves testing the feasibility of recruitment and data collection procedures planned for a multi-center trial of decision aids in older patients with MCI and normal cognition hospitalized with a Type 1 non-ST-elevated myocardial infarction (NSTEMI), care partners, and clinicians.
Pilot 2 involves conducting interviews of individuals with normal cognition and MCI, identified by the Michigan Alzheimer’s Disease Center (MADC). These interviews tested the effectiveness of a heart attack treatment decision aid and validation of a brief survey consisting of two sections asking questions about knowledge and values. A mailing of surveys to an additional 258 MADC-identified individuals was done in July 2023 with a goal of receiving 100 completed surveys to provide preliminary data for the grant submission.